ReviewDrug design, development and therapy2026

Antifibrotics with Cross-Indication Potential: Challenges and Progress Towards a Universal Fibrosis-Modifying Therapy.

Claudia Gyimah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.